NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

HyGro,

About the number 50, I read it somewhere about an interview with Dr. Liau. In the phase 3 trial, we have 27 patients still alive. How many patients enrolled in the expanded access program? I think it is over 100. For nGBM, five years survival rate is 13%. So we most likely have over 13 patients who are alive today. That makes the number over 40. NWBO also has compassionate use program. DCVax-L also has some patients from phase 1. If we add them all together, 50 strikes me as pretty reasonable number. Will the number 50 qualify NWBO for CBS 60 show? If polio virus therapy can, in which case all patients passed away in the end, DCVax-L therapy certainly can.